ArticleOncogene2000

Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.

S P Newman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.